Enbridge (ENB) sees strong EBITDA growth amid long-term demand tailwinds. Strategic M&A deals and undervalued stock signal a ...

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

Five companies eligible for inclusion in our IPO stats went public this week, joined by four SPACs and a nano-cap.

Learn more about the potential of iShares MSCI Chile ETF (ECH) amid election-driven shifts. Analyze low valuations, economic ...

General Dynamics is a strong buy. With a $90B backlog, defense growth, and expanding aerospace segments, see more on GD stock ...

Lonza is poised for growth amid margin recovery, onshoring opportunities, and strong profit projections. Read more on LZAGY ...

Lavras Gold Corp recently discovered gold in Brazil. Read more on LGC:CA stock's funding, exploration efforts and stock ...

Super Micro Computer is rated a Buy for its strong AI-driven revenue growth despite risks like governance and volatility.

The iShares MSCI Poland ETF (EPOL) is a buy despite market volatility. EPOL ETF offers exposure to a broad range of Polish ...

Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

Daniel Ghali, Director, Commodities Strategy at TD Securities, breaks down what it could mean for oil, gold and the wider ...

Demand for gold from central bankers continues, with data available for February showing reported global central bank gold ...